In-vitro and In-vivo Studies on the Effect of Using Single and Combinations of Antibiotics on Different Phases of Bacterial Growth  by Sulieman, S.M.
13th International Congress on Infectious Diseases Abstracts, Poster Presentations e177
21.027
Construction and Histopathological Characterization of
Multiple Virulent Genes Mutant of V. cholerae: To Under-
stand the Enteropathogenesis of Cholera
M. Chandrika1,∗, G.C. Tan2, M.A. Nurul Ashikin2, M. Chan2,
N.M.N. Nik Zuraina2, S. Kurunathan2, M. Shyamoli 1, M.
Ravichandran2, P. Lalitha1
1 School of Health Sciences, Universiti Sains Malaysia,
Kubang Kerian, Malaysia
2 Department of Medical Microbiology and Parasitology,
School of Medical Sciences, Universiti Sains Malaysia,
Kubang Kerian, Malaysia
Cholera is caused by toxigenic V. cholerae that secretes
the cholera toxin (CT) encoded by ctx gene. Although CT
is the major toxin, accessory toxins rtx gene encoding RTX
toxin and hap gene that secretes hemagglutinin/protease
(HA/P) have been shown to elicit mild diarrhoea and
inﬂammatory reactions. The present study was designed
to produce a V. cholerae O139 vaccine candidate hav-
ing multiple virulent genes mutation and study their
enteropathogenesis in animal model. The ctx, rtx and
hap genes were mutated individually by allele replace-
ment method and the vaccine candidate were named as
VCUSM14P, VCUSM10P and VCUSM17P respectively. A multi-
toxin - deﬁcient mutant (VCUSM22P) was created that have
all 3 genes mutated. The mice colonization ability in all
the above mentioned individual and multitoxin - deﬁcient
mutants were good and were 1 log lower that of wild type
(WT) strain. In ileal loop assay, no ﬂuid accumulation were
seen in VCUSM14P and VCUSM22P which have the ctx gene
mutated, while VCUSM10P and VCUSM17P showed more ﬂuid
accumulation as seen in the WT strain due to the presence
of intact ctx gene. The histopathological studies, correlated
with the ﬂuid accumulation data wherein the tissue sec-
tions infected with VCUSM14P and VCUSM22P showed the
presence of intact villi, intestinal gland with no damage in
the submucosa, muscularis or serosal layer. But VCUSM10P
and VCUSM17P caused sloughing of the villi, mild to mod-
erate haemorrhage, congested blood vessel in submucosa
and PMN in the lamina propria, as in tissue infected with
WT strain. The histopathological features were further con-
ﬁrmed by immunohistochemical analysis. Thus it is clear that
the mutation of only accessory toxins (RTX and HA/protease)
caused only modest changes in virulence. While multitoxin
- deﬁcient mutant (VCUSM22P) are potent vaccine candi-
date which shows better colonization, low virulence with no
enteropathogenic, cytopathic and haemolytic effects.
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Background: In our few working Sudanese microbiologi-
cal laboratories, sensitivity testing for isolated organisms is
usually performed using the disc method. The disc method
tests for the sensitivity of a single antibiotic at different con-
centrations. Accordingly the antibiotics are judged whether
they are effective (sensitive) or ineffective (resistant). In
this test, the bacteria used are always in the stationary
phase or declining phase. This situation does not answer
several important questions.
Is it possible to overcome bacterial resistance by using
different combinations of commonly used antibiotics? Do
bacteria at different phases of growth, starting from lag
phase to declining or death phase behave similarly in their
sensitivity to various combinations of antibiotics? Are the
effects of these combinations the same in vivo as in vitro?
The aim of the present study is to render available a clue
about the use of combinations antibiotics so as to ﬁnd out the
most effective time of starting the treatment by antibiotics,
at the beginning of onset of disease or latter when symptoms
have clearly developed in both man and animals. This aim
can be achieved through the following objectives:
1. To test the sensitivity of selected resistant Gram negative
organisms to combinations of commonly used antibiotics
in Sudan.
2. To compare the sensitivity of bacteria at different phases
of growth to antibiotics when using single antibiotic or
combinations of antibiotics.
3. To monitor in vivo the sensitivity of selected bacteria at
different phases of growth to single and combinations of
antibiotics, which were found to be effective in vitro.
Methods: Bacterial strains and susceptibility testing
Pasturella multocida local sensitive strain to most of the
antibiotics which are commonly used in Sudan had been used
in these studies.
Antibiotics Erythromycin and tetracycline each sepa-
rately and in combination were used in these experiments.
In vitro studies (growth curve with antibiotics)
Ten-ml sterile bottles of nutrient broth were inoculated
by a colony or part of a colony of Pasteurella multo-
cida. The inoculum was emulsiﬁed carefully and the bottle
was incubated at 37 ◦C for 18 hours. Eight bottles con-
taining 99ml Mueller Hinton Broth each were prepared
and were inoculated with one ml from the overnight
culture. The eight were labeled time zero, one hour,
two hours, four hours, six hours, eight hours and twenty
four hours. From the ﬁrst bottle (at zero time) one ml
was discarded and replaced by one ml normal saline
containing the tested antibiotic of 1 MIC concentration (ery-
thromycin = 2gm/ml, tetracycline = 4gm/ml and combi-
nation of erythromycin/tetracycline = 0.125/0.25gm/ml).
The antibiotic was allowed to act for 15 minutes then
the viable count was done. The other seven bottles were
incubated at 37 ◦C for 1 hour, 2 hours, 6 hours, 8 hours and
24 hours respectively. After the inoculum time 1ml was dis-
carded and replaced by 1ml normal saline containing the
antibiotic of 1 MIC concentration. Then after 15minutes
viable count using Miles and Misra (1938) method was done.
The results of the viable count were compared with a
standard curve for Pasteurella multocida (control) without
the addition of any antibiotic.
In vivo studies.
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Animals: White mice weighing approximately 23—28 g
were used throughout this study. Animals were allowed, at
least 72 h after delivery, to acclimatize to laboratory sur-
roundings before experimentation.
Minimum lethal dose determination (MLD).
The minimum lethal dose, the lowest diluton of organ-
isms at which 100% mortality occurred, was determined by
intraperitoneal injection of groups of mice (three per group)
with 0.5ml of bacteria in Mueller-Hinton broth at serial 10-
fold dilutions.
Animals were observed for 24 hours, and the rate and
number of deaths at each dilution were recorded.
For each MLD determination, a control group of mice
received normal saline instead of the bacterial suspension.
Experimental infection: Infection was produced in by
intraperitoneal injection of 0.1ml of broth containing
approximately 1.2× 107 CFU of bacteria per ml (10×MLD).
Antibiotics treatment: The mice were divided at random
into three groups; each group contained three sub groups
each consisting of three animals.
In the ﬁrst group of experiments (group 1), 0.1ml of
tetracycline was administered intravenously at 0 h (= time of
infection) and three hours afterwards at the indicated dose
of 25mg/kg of body weight to the ﬁrst sub group.
The second sub group set of experiments 0.1ml of ery-
thromycin was administered intravenously at 0 h (= time of
infection) and three hours afterwards at the indicated dose
of 30mg/kg of body weight to the second sub group.
The last sub group was performed with erythromycin and
tetracycline in combination.
For each sub group, a control group of mice received
normal saline instead of the bacterial suspension.
Animals were observed for 24 hours, and the rate and
number of deaths at each dilution were recorded.
Results: In vitro studies on effect of using single and com-
bination antibiotics on different bacterial growth phases.
The results shows that the maximum numbers of viable
cells of Pasteurella multocida were killed when ery-
thromycin was added to 6 hours growing cells. Addition of
tetracycline resulted in decrease in the viable cell count
at 1-2 hours and 6 hours. When combination of two antibi-
otics with lower concentration than each singly was used,
the maximum numbers of bacteria were killed at 2 hours
and 6 hours.
In vivo studies on effect of using one or two antibiotics
on different bacterial growth phases.
The results show that 100% of the animals survived when
combination of erythromycin and tetracycline was used
either half an hour after infection or after 8 hours. Using
the combination after 3 hours of infection resulted in the
cure of 67% of the infected animals.
When using erythromycin alone, only 33% of the infected
animals survived when the dose was administrated after
3 hours of infection. Where as when using tetracycline alone,
33% of the animals survived when the dose is administrated
at the beginning of infection.
Conclusion: From the above results we can conclude that
Pasteurella multocida is sensitive to combination of ery-
thromycin and tetracycline in vivo as well as in vitro. We
can also conclude that different antibiotics have different
effects on the cells of Pasteurella multocida at different
phases of growth.
The experiments reported here also suggest that the
variable of bacterial growth phase should be further evalu-
ated and standardized for quantitative testing of antibiotic
susceptibility in vitro. Additional information is needed con-
cerning the importance of the growth phase in killing by
agents other than what we used either singly or in com-
bination and on the correlations between the responses of
bacteria to antimicrobial agents in vitro and in vivo.
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Background: Sexually transmitted diseases (STDs) remain
major public health problem in Nigeria, as in other parts
of the world. Urogenital Chlamydial infections, caused by
Chlamydia trachomatis, are considered the most prevalent
non-gonococcal STD. Most urogenital chlamydial infections
are asymptomatic and failure to diagnose and treat the
infection at an early stage may result in serious complica-
tions and sequalae, such as infertility. Information regarding
the involvement of urogenital chlamydial infections in infer-
tility is lacking in Anambra State of Nigeria, and hence the
need for this study.
Materials and Methods: The study population comprised
males (42) and females (100), who were receiving treat-
ment for infertility between August and December, 2003;
ninety of the subjects were cases of primary infertility,
while 52 had secondary infertility. Twenty three (61%) were
asymptomatic. Questionnaires were served, and sera appro-
priately collected. Chlamydia antibodies were sought by
ELISA techniques, using Chlamydia trachomatis IgG serodi-
agnostic test kits, as well as IgM kits.
Results: Thirty-eight (27%) of the patients were seropos-
itive for C. trachomatis antibodies. Chlamydia antibodies
were slightly more prevalent in infertile females (28 or
28%) than males (10 or 24%). Majority (33%) of seropositive
individuals had 2 or more sexual partners. Rate of seroposi-
tivity was highest among individuals in 26-40yrs age bracket
(28 or 32%). Presence of Chlamydia antibodies was most
prevalent in males and females employed in corporate orga-
nizations (44%), followed by those in private business (30%).
Seropositivity was more frequently observed among those
with secondary infertility than in those with primary infer-
tility. Prevalence of antichlamydial antibodies reduced with
increasing exposure to secular education.
Conclusion: It could be concluded that Chlamydia tra-
chomatis - associated infertility is a problem in Anambra
state of Nigeria, particularly among those having multiple
sex partners. It is suggested that Chlamydia tests be included
among the routine medical investigations in this locality.
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